Balyasny Asset Management’s Revolution Medicines RVMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.31M Sell
23,799
-391,408
-94% -$39.5M ﹤0.01% 1721
2025
Q4
$33.1M Buy
415,207
+319,611
+334% +$21M 0.06% 498
2025
Q3
$4.46M Buy
+95,596
New +$3.74M 0.01% 1417
2025
Q1
Sell
-1,302,848
Closed -$57M 3271
2024
Q4
$57M Sell
1,302,848
-348,957
-21% -$17.6M 0.13% 289
2024
Q3
$74.9M Sell
1,651,805
-711,779
-30% -$31M 0.19% 181
2024
Q2
$91.7M Buy
2,363,584
+708,689
+43% +$26.5M 0.24% 143
2024
Q1
$53.3M Buy
1,654,895
+1,087,790
+192% +$32.2M 0.14% 282
2023
Q4
$16.3M Sell
567,105
-395,552
-41% -$9.5M 0.05% 685
2023
Q3
$26.6M Buy
+962,657
New +$28.6M 0.07% 476
2021
Q3
Sell
-75,137
Closed -$2.38M 2446
2021
Q2
$2.38M Sell
75,137
-44,915
-37% -$1.57M 0.01% 963
2021
Q1
$5.51M Buy
+120,052
New +$5.38M 0.03% 665

Other funds holding RVMD